Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

Sales rise 128.01% to Rs 9.28 crore

Net Loss of Parmax Pharma reported to Rs 0.22 crore in the quarter ended September 2024 as against net loss of Rs 1.37 crore during the previous quarter ended September 2023. Sales rose 128.01% to Rs 9.28 crore in the quarter ended September 2024 as against Rs 4.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales9.284.07 128 OPM %2.05-18.92 -PBDT0.18-0.94 LP PBT-0.22-1.37 84 NP-0.22-1.37 84

Powered by Capital Market - Live News